Millennium Management
RCKT icon

Millennium Management’s Rocket Pharmaceuticals RCKT Stock Holding History

Millennium Management’s Portfolio RCKT Stock Details RCKT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-20,000
Closed -$887K – 7003
2021
Q1 		$887K Buy
+20,000
New +$1.1M ﹤0.01% 4337

Other funds holding RCKT

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
NM
Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Millennium Management's RCKT Position: Q1 2026 in Review

Millennium Management increased its Rocket Pharmaceuticals (RCKT) stake by 75% in Q1 2026, buying an estimated $5.3M and bringing the position to 3,118,124 shares worth $11.2M. The position accounts for ﹤0.01% of the portfolio, ranked #2066.

Millennium Management first reported a position in RCKT in Q4 2015 and has held it in 35 quarters since. The position peaked at $22.2M in Q3 2024. 198 funds tracked by Wall St. Rank hold RCKT as of Q1 2026.

  • Millennium Management held 3,118,124 shares of Rocket Pharmaceuticals worth $11.2M as of Q1 2026.
  • Millennium Management bought 1,333,203 Rocket Pharmaceuticals shares in Q1 2026, an estimated $5.3M.
  • Rocket Pharmaceuticals made up ﹤0.01% of Millennium Management's portfolio in Q1 2026, its #2066 holding.
  • Millennium Management first reported a position in Rocket Pharmaceuticals in Q4 2015 and has held it in 35 quarters since.
  • Millennium Management's Rocket Pharmaceuticals position peaked at $22.2M in Q3 2024.
  • 198 funds tracked by Wall St. Rank held Rocket Pharmaceuticals as of Q1 2026.

Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.